Cargando…
HER 2/neu protein expression in colorectal cancer
BACKGROUND: Conflicting data exist about the prevalence of HER-2/neu overexpression in colorectal cancer ranging from 0 to 83 %. In our study we tried to clarify the extent of expression and its relationship to clinicopathological parameters. METHODS: This study involved 77 specimens of malignant co...
Autores principales: | Schuell, B, Gruenberger, T, Scheithauer, W, Zielinski, Ch, Wrba, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475876/ https://www.ncbi.nlm.nih.gov/pubmed/16681853 http://dx.doi.org/10.1186/1471-2407-6-123 |
Ejemplares similares
-
Side effects during chemotherapy predict tumour response in advanced colorectal cancer
por: Schuell, B, et al.
Publicado: (2005) -
Expression of Septin 2 and Her2/neu in Colorectal Cancer
por: Hanbuli, Hala M. El, et al.
Publicado: (2021) -
HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014) -
Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005) -
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
por: Gruenberger, Birgit, et al.
Publicado: (2008)